IPG Photonics Corporation (IPGP)

IPG makes fiber lasers, fiber amplifiers, diode lasers and laser-based systems, used mainly to process materials and also in medicine and in advanced applications such as directed energy, sensing and spectroscopy. In a fiber laser, semiconductor diodes pump light into a specialty optical fiber about as thin as a human hair and laced with rare earth elements; the beam forms inside the fiber and leaves through a flexible cable. Its lasers run from 1 watt to 1,000 watts and above, as a steady beam (CW, continuous wave), in long pulses (QCW, quasi-continuous wave) or in pulses as short as femtoseconds. Around them it sells delivery cables, couplers, beam switches, chillers and scanners, and it builds complete systems: LightWELD handheld welders, precision systems for medical device makers, flat-sheet cutters, laser cleaning systems and, through its Genesis Systems Group subsidiary, robotic welding and automation. 262728293031323334

How it operates

IPG makes fiber lasers, fiber amplifiers, diode lasers and laser-based systems, used mainly to process materials and also in medicine and in advanced applications such as directed energy, sensing and spectroscopy. In a fiber laser, semiconductor diodes pump light into a specialty optical fiber about as thin as a human hair and laced with rare earth elements; the beam forms inside the fiber and leaves through a flexible cable. Its lasers run from 1 watt to 1,000 watts and above, as a steady beam (CW, continuous wave), in long pulses (QCW, quasi-continuous wave) or in pulses as short as femtoseconds. Around them it sells delivery cables, couplers, beam switches, chillers and scanners, and it builds complete systems: LightWELD handheld welders, precision systems for medical device makers, flat-sheet cutters, laser cleaning systems and, through its Genesis Systems Group subsidiary, robotic welding and automation. 262728293031323334

It sells to OEMs (original equipment manufacturers, meaning machine builders that put its lasers into their own machines), to system integrators and to end users, mainly through its own sales force; once a laser is designed into an OEM's machine, the OEM's own sales force markets that machine. It has thousands of customers and no dominant one: the five largest took 16% of 2025 sales, up from 13% in each of the two years before, though a single customer accounted for 11% of what customers owed it at the end of 2025. Materials processing brought in 85.7% of 2025 sales, medical procedures 7.4% and advanced applications 6.9%. In medicine it makes complete thulium fiber laser systems and consumable fibers for urology, for treating an enlarged prostate and breaking up urinary stones, and it sells complete medical systems and fibers to medical technology companies that sell them under their own names. In 2023 it formed a partnership with Miller Electric, a leading maker of arc welding products, to promote handheld laser welding. 3536373839404142434445

IPG is vertically integrated, meaning it makes most of the key parts of its products itself. It runs its own semiconductor foundry for the diodes that pump its lasers, and makes optical preforms and specialty fiber, optical components, fiber laser modules, power supplies, electronics, chillers and cabinets before final assembly. It buys some wafer substrates, diode packages, optics and beam delivery parts from single or limited-source suppliers, which it describes as relatively small private companies, some of them competitors. Its factories are in the United States, Germany, Italy and Poland; its largest sites include Burbach, Germany (586,800 square feet: fiber, components and complete devices) and Oxford, Massachusetts (550,300 square feet: diodes, components and complete devices). Owning so much plant means high fixed costs, so, by the filing's own account, gross margin rises and falls with sales volume and how fully the factories run. 464748495051525354

Most of its sales are made outside the United States, and it does business in the local currency of most countries where it operates. China, which the filing calls its largest market, took 29% of 2025 sales, up from 25% a year earlier, and is supplied with finished products from the US and German factories. North America, mostly the United States, took 26.6%; Germany 10.5% and the rest of Europe 13.8%; Japan 6.6% and the rest of Asia 12.1%. Sales are generally made on purchase orders rather than long-term purchase commitments. 555657585960

The specifics

The filing credits fiber lasers with being more reliable, efficient, compact and easier to run than the gas, crystal and solid-state lasers industry first used, and IPG says it makes the highest power solid-state lasers in the industry, with ytterbium fiber lasers of up to 125,000 watts. It holds that making its own key parts lowers its costs and improves performance: it grows its diode wafers by molecular beam epitaxy, a way of building crystals layer by layer, and tests every diode at high current and temperature to weed out weak ones. It protects this with over 900 issued patents and over 450 pending applications at the end of 2025, alongside trade secrets and contracts, and says the business as a whole does not depend on any single patent. 6162636465666768

Competition is stiff, and prices fall as products mature. In materials processing it names Coherent, JPT Opto-Electronics, Laserline, Lumentum, Maxphotonics, MKS Instruments, nLight, Trumpf and Wuhan Raycus, and warns that rivals, particularly in China, have cut prices to win share, that Asian makers are starting to export beyond Asia, and that some customers make competing products for their own use. Trumpf also took IPG to court: in December 2024 its affiliates sued IPG's German subsidiary in two Unified Patent Courts located in Germany, saying IPG's adjustable mode beam lasers, used in welding and cutting, infringed two patents. The courts upheld the patents and found infringement in February and March 2026; under a settlement effective May 1, 2026, IPG paid a lump sum, recording 13.5 million dollars of settlement charges in the first half, and took a worldwide license to both patents in exchange for a royalty. 6937071727374757677

The business began operations in 1990 and was incorporated in Delaware in 1998, and recent years remade it. It sold its telecom transmission product lines in August 2022. After the Russia-Ukraine conflict and sanctions curtailed its shipments to and from its Russian operations, it sold its Russian subsidiary, IRE-Polus, in August 2024 to a buyer tied to Softline Projects and IRE-Polus's own management for 51.1 million dollars, at a loss of 197.7 million. EU sanctions restricted its Belarus plant from supplying laser cabinets and other mechanical parts to its German operations after October 2024, and in the second quarter of 2026 it agreed to sell that business. In December 2024 it bought cleanLASER, a maker of laser cleaning systems, paying 66.7 million dollars in cash. On September 8, 2026 it signed an agreement to buy Lumibird Medical, a French maker of diagnostic and laser treatment systems for the eye with more than 450 employees, for 300 million euros in cash plus up to 50 million euros more tied to 2026 and 2027 results, which it expects to pay from cash on hand; closing, subject to French approvals, is expected in the fourth quarter of 2026. 787980818283848586878889909192

Rules reach the business in several ways. Most of its lasers sold in the United States are Class IV laser products, the highest of the laser hazard classes, under the FDA's radiological health rules, which require self-certification, product reports and labeling. Its trade falls under US, European and German export controls and sanctions, including the US rules on arms exports, and its CROSSBOW counter-drone systems, offered to governments and other authorized buyers, face additional regulation of their own. Tariffs cut its 2025 gross margin by about 120 basis points (hundredths of a percentage point); after the Supreme Court held in February 2026 that the emergency economic powers law does not authorize tariffs, it applied for refunds, and it recognized 5.1 million dollars of tariff recoveries in the first half of 2026. 93949596979899100101

What drives growth, line by line

Revenue rose 2.7% in 2025 to 1,003.8 million dollars, the first rise since 2021, after a 24% fall in 2024. Materials processing, 85.7% of sales, was flat: lower sales for cutting were offset by cleaning, mainly thanks to the cleanLASER purchase, and by additive manufacturing (building metal parts layer by layer), micromachining, drilling and annealing. Sales for other uses rose 19.9%, led by advanced applications and medical procedures. By region, China grew 19.1% to 291.9 million dollars, 29.1% of sales, and North America rose 3.2%. Europe fell, which the filing puts down to weaker cutting and welding and the sale of the Russian business, partly offset by cleaning and additive manufacturing: Germany rose 19.8% while the rest of Europe fell 29.7%. 10210310410559106

High Power Continuous Wave CW Lasers. The largest line and the one that shrank most: 308.8 million dollars, 30.8% of 2025 revenue, down 7.2%, and down from 41% of revenue two years earlier. These are lasers of 1,000 watts and more; the filing lists continuous wave lasers of that power for welding and for cutting. It gives no reason line by line, but its account of the year points to lower sales for cutting and, in Europe, lower cutting and welding sales. 5910730108109104106

Amplifiers Laser Systems Service Parts Accessories. The filing's catch-all line of other lasers, amplifiers, service, parts and accessories: 264.5 million dollars, 26.4% of revenue, up 7.2%. The filing does not explain it on its own. Within materials processing it reports lower sales of service and parts, while sales rose for advanced applications, where its lasers and amplifiers serve commercial, academic and government users, and for medical procedures. 59110104105111

Laser and Non Laser Systems. Complete systems rather than laser sources: 147.2 million dollars, 14.7% of revenue, up 5.8%, a share that has climbed from 13% two years earlier. The filing credits the cleanLASER purchase for most of the growth in cleaning sales; cleanLASER added laser cleaning systems, a dry alternative to abrasive or chemical cleaning, to the handheld welders, cutting systems and robotic welding it already sold. 59112104333234

Pulsed Lasers. 143.3 million dollars, 14.3% of revenue, down 2.4%, a share that has stayed near one seventh for three years. Pulsed lasers fire in short bursts, from nanoseconds down to femtoseconds, and the filing lists them for marking and engraving, surface cleaning and the cutting of thin foil in electric vehicle batteries. It gives no reason for the line's small decline. 5910730113114115

Medium and Low Power CW Lasers. The fastest-growing line: 88.2 million dollars, 8.8% of revenue, up 38.5%. These are continuous wave lasers below 1,000 watts. The filing gives no reason line by line. The proxy statement says micromachining, medical and advanced applications sales all rose by double digits in 2025, and the annual report names additive manufacturing among the gains in materials processing. 5930116104

Quasi Continuous Wave QCW Lasers. The smallest line: 51.8 million dollars, 5.2% of revenue, up 7.8%. Quasi-continuous wave lasers run in long, strong pulses rather than a steady beam; the filing lists them for welding, cutting and marking and for the percussion drilling of aerospace parts, and drilling was among the uses whose sales rose in 2025. 59108109113117104

What comes next, in the company's own words: the order backlog stood at about 631.5 million dollars at the end of 2025, against 636.2 million a year earlier; 232.5 million of it was frame agreements, which are not binding, and orders can generally be cancelled without substantial penalties. The company anticipates shipping a substantial majority of the backlog during 2026. The newest quarterly report shows sales up 13.7% in the first half of 2026, to 544.1 million dollars. 118119120121122

The company expects to keep investing in research and development for medical, micromachining and advanced applications, and expects the purchase of Lumibird Medical to close in the fourth quarter of 2026. Its chief executive says Lumibird Medical's leadership in eye care complements IPG's strength in urology and will create a scaled medical platform. 12392124

The read's section on the people who run it is on the People tab.

What the desk infers Inferred

1. Inferred

   All of IPG's lasers appear to rest on a single diode plant, most likely its Oxford, Massachusetts site: every fiber laser it sells is pumped by diodes it makes itself, and it has no second production line for them.

   Because

   • Its fiber lasers use semiconductor diodes as their energy source, and its platform combines many single-emitter diodes with the active fibers used in all of its products. 28125
   • It relies only on its own production for diodes, which it says are made at a single manufacturing facility with no redundant production line. 126
   • It runs its own semiconductor foundry for the diodes that pump its lasers. 47
   • Of the significant sites it lists, only Oxford, Massachusetts names diodes among its work; Burbach, Germany names optical fiber, components and complete devices. 5352
   Confidence 75 of 100Wrong if A filing that places diode production at a second site, such as Burbach, or names an outside supplier qualified to make its pump diodes in volume.
2. Inferred

   The better gross margin of 2025 came from fuller factories and smaller inventory write-downs rather than firmer prices; with selling prices under steady pressure, IPG's profit depends on keeping volume flowing through plants it largely owns.

   Because

   • Gross margin rose to 38.0% from 34.6%; the year before carried 29.5 million dollars of extra inventory provisions, and unabsorbed manufacturing costs fell by 20.9 million dollars, partly offset by higher product costs and tariff duties. 127128
   • The proxy statement credits improved manufacturing cost absorption and lower inventory provisions for the rise. 129
   • The filing says its products face a significant decline in average selling prices, with rivals, particularly in China, cutting prices to win share. 13070
   • Its vertical integration carries high fixed manufacturing overhead, so gross margin follows sales volume and how fully the factories run. 54
   Confidence 70 of 100Wrong if A filing that credits higher selling prices for a meaningful part of the 2025 gain in gross margin, or reports average selling prices rising for its main laser lines.
3. Inferred

   Lumibird Medical, the eye-care business IPG has agreed to buy, is larger than IPG's own medical line, so the purchase is a change of scale for IPG in medicine rather than a small add-on.

   Because

   • Lumibird Medical reported revenue of 112.2 million euros for 2025. 131
   • IPG's own medical procedures sales were 7.4% of its 2025 net sales of 1,003.8 million dollars. 41102
   • A euro was worth more than a dollar: the filing's average rate for 2024 was 0.92 euro to the dollar. 132
   • Its chief executive says the deal pairs Lumibird Medical's leadership in eye care with IPG's strength in urology to create a scaled medical platform. 124
   Confidence 85 of 100Wrong if Filed figures showing Lumibird Medical's 2025 revenue, converted to dollars, below IPG's own 2025 medical procedures sales.